Trademark: 79045357
Status Date
Monday, June 26, 2017
Registration Number
3643630
Registration Date
Tuesday, June 23, 2009
Filing Date
Monday, June 25, 2007
Published for Opposition
Tuesday, April 7, 2009
Cancellation Date
Monday, June 26, 2017
1 Chemical products for use in industry and science for use in gene delivery technology and the manufacture of pharmaceuticals and retroviral vector preparations; enzymes for laboratory and research use; chemical products for in vitro use in laboratories and for analysis, namely, for use in gene delivery technology, micro-organisms for laboratory and research use, cell cultures for laboratory and research use, plasmids and cultures of micro-organisms for laboratory and research use, deoxyribonucleic acid sequences for laboratory and research use, cloning vehicles, namely, chemical preparations for scientific purposes for use in biotechnology, research and development and recombinant deoxyribonucleic acid variations thereof for laboratory and research use, all for in vivo use; none of the goods in this class for medical or veterinary purposes; none of the foregoing goods including or for use in connection with the immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens
5 Gene therapy products for medical use, namely, clinical medical reagents, liposome reagents, nucleic acids, and vaccines for use in gene therapy, gene-based medicines, chemotherapeutics, and pharmaceutical preparations for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, neuro-degenerative disorders, cardiac disorders, cystic fibrosis, inflammatory and auto-immune diseases; enzymes and enzyme preparations for medical purposes for use in gene delivery technologies; retroviral vector manufacturing preparations and retroviral vector preparations for medical use for gene delivery technologies; chemical products for medical use for genetic engineering and in gene therapy; none of the foregoing goods including or for use in connection with immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens
10 Instruments and apparatus for the administration of gene therapy products, namely, injection devices, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments, namely, injection devices, syringes, scalpels, catheters, tubes for medical services, none being blood circulatory apparatus and instruments, blood pumps, flow probes for blood pumps or blood circulatory devices for medical purposes
42 Scientific and medical research in the fields of genetic engineering and gene therapy and scientific and medical development in the fields of genetic engineering and gene therapy, genetic engineering services and gene therapy and prophylaxis for the development and commercialization of therapeutic vaccines and gene-based therapies, namely, development of new technology for others in the field of biotechnology, collaboration for others with other biomedical and pharmaceutical entities for the commercialization of therapeutic vaccines and gene-based therapies; none of the foregoing services including or for use in connection with the immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens
Jan 11, 2018
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Jan 11, 2018
Death Of International Registration
Feb 3, 2017
Total Invalidation Processed By The Ib
Sep 29, 2016
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 29, 2016
Invalidation Processed
Sep 29, 2016
Total Invalidation Of Reg Ext Protection Created
Jan 29, 2016
Cancelled Section 71
Jan 12, 2013
Final Decision Transaction Processed By Ib
Sep 28, 2009
Final Disposition Notice Sent To Ib
Sep 28, 2009
Final Disposition Processed
Sep 23, 2009
Final Disposition Notice Created, To Be Sent To Ib
Jun 23, 2009
Registered-Principal Register
May 7, 2009
Notification Of Possible Opposition - Processed By Ib
Apr 23, 2009
Notification Of Possible Opposition Sent To Ib
Apr 23, 2009
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 7, 2009
Published For Opposition
Mar 18, 2009
Notice Of Publication
Feb 27, 2009
Law Office Publication Review Completed
Feb 25, 2009
Approved For Pub - Principal Register
Feb 25, 2009
Examiner's Amendment Entered
Feb 25, 2009
Notification Of Examiners Amendment E-Mailed
Feb 25, 2009
Examiners Amendment E-Mailed
Feb 25, 2009
Examiners Amendment -Written
Feb 3, 2009
Teas/Email Correspondence Entered
Feb 3, 2009
Correspondence Received In Law Office
Jan 26, 2009
Teas Request For Reconsideration Received
Jan 26, 2009
Ex Parte Appeal-Instituted
Jan 26, 2009
Jurisdiction Restored To Examining Attorney
Jan 26, 2009
Exparte Appeal Received At Ttab
Dec 17, 2008
Teas Change Of Correspondence Received
Dec 17, 2008
Teas Change Of Correspondence Received
Jul 26, 2008
Notification Of Final Refusal Emailed
Jul 26, 2008
Final Refusal E-Mailed
Jul 26, 2008
Final Refusal Written
Jun 2, 2008
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 2, 2008
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 30, 2008
Teas/Email Correspondence Entered
May 29, 2008
Correspondence Received In Law Office
May 30, 2008
Teas/Email Correspondence Entered
May 30, 2008
Correspondence Received In Law Office
May 30, 2008
Assigned To Lie
May 29, 2008
Teas Response To Office Action Received
Dec 21, 2007
Refusal Processed By Ib
Nov 29, 2007
Non-Final Action Mailed - Refusal Sent To Ib
Nov 29, 2007
Refusal Processed By Mpu
Nov 29, 2007
Non-Final Action (Ib Refusal) Prepared For Review
Nov 28, 2007
Non-Final Action Written
Nov 26, 2007
Assigned To Examiner
Nov 26, 2007
New Application Entered In Tram
Nov 22, 2007
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
